DRG INTERNATIONAL INC has a total of 12 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets measurement, biotechnology and machines are BIOMOLECULAR ENGINEERING RES I, IGAKU SEIBUTSUGAKU KENKYUSHO KK and BIOREALITES S A S.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology | |
#3 | Machines | |
#4 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Analysing materials | |
#3 | Unspecified technologies | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Janetzko Alfred | 12 |
#2 | Geacintov Cyril E | 12 |
#3 | Kulaksiz Hasan | 12 |
#4 | Stremmel Wolfgang | 10 |
Publication | Filing date | Title |
---|---|---|
WO2008089795A1 | Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids, monoclonal antibodies specific to human hepcidin and associated uses therefor | |
AU2003295644A1 | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor | |
US2004096987A1 | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids |